🇺🇸 FDA
Patent

US 8940288

Method for treating cancer by administering IL-15 and IL-15Ralpha complexes

granted A61KA61K38/00A61K38/1793

Quick answer

US patent 8940288 (Method for treating cancer by administering IL-15 and IL-15Ralpha complexes) held by UNIVERSITY OF CONNECTICUT expires Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Jan 27 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 22 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61K, A61K38/00, A61K38/1793, A61K38/2086, A61P